Effect of chest tube position on the success rate of pleurodesis: A retrospective cohort study
Open Access
- 1 October 2017
- journal article
- Published by Wolters Kluwer Health in The Egyptian Journal of Chest Diseases and Tuberculosis
- Vol. 66 (4) , 635-638
Abstract
Background: Malignant pleural effusion reduces cancer patients’ quality of life. Some experts have suggested that chest tubes should be directed posteriorly during pleurodesis. We conducted this study to clarify whether a posteriorly positioned chest tube has a better success rate than does an interlobular or anterior one. Methods: We performed a retrospective chart review of patients undergoing pleurodesis between April 2011 and September 2016, and 86 patients were enrolled and divided into two groups based on the chest tube position: posterior (group 1) and others [interlobular and anterior (group 2)]. The primary endpoint was the success rate of pleurodesis, and the secondary endpoint was the complication rate (pain and fever). P < 0.05 was considered to be significant. Results: In total, 66, 20 patients were included in groups 1 and 2, respectively. Complete and partial success was achieved in 57 (86%) and 15 (75%) patients in groups 1 and 2, respectively. The success rates were similar in all groups (p = 0.39). Complications were observed in 51 (77%) and 16 (80%) patients in groups 1 and 2, respectively (p = 0.99). Between the two groups, there was no statistically significant difference in terms of age and sex. Conclusions: In malignant pleural effusion, the success rates of pleurodesis may be similar regardless of the position of the tube. However, this is a retrospective study with insufficient participants. Hence, further investigation is requiredKeywords
This publication has 9 references indexed in Scilit:
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Mapping the Risk of Mesothelioma Due to Neighborhood Asbestos ExposureAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Efficacy of Iodopovidone Pleurodesis and Comparison of Small-Bore Catheter Versus Large-Bore Chest TubeAnnals of Surgical Oncology, 2008
- Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515Lung Cancer, 2007
- The evidence on the effectiveness of management for malignant pleural effusion: a systematic reviewEuropean Journal of Cardio-Thoracic Surgery, 2006
- Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural EffusionChest, 2005
- Pleurodesis for malignant pleural effusions2004
- Management of Malignant Pleural EffusionsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Pleural Fluid pH as a Predictor of Pleurodesis FailureChest, 2000